One hundred and seventy-seven patients were diagnosed to have grade IV GBM, 6 patients had grade III glioma with nonmutated IDH, and 15 patients were diagnosed by imaging only; therefore, their tumor grade and IDH1 status were indeterminate. This evidence concerns the gene IDH1 and central nervous system cancer.